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Background: Colorectal sessile serrated adenoma/polyps (SSA/Ps) are characterized by asymmetrical distribution of
Ki67-positive cells, which varies among crypts and involves the crypt length to a variable extent; the pattern has
been designated as aberration of crypt cell compartmentalization. The regenerating gene (REG) Iα is a cell growth and/or
anti-apoptotic factor and its overexpression might be associated with aberration of crypt cell compartmentalization in
SSA/Ps. We investigated REG Iα expression in SSA/Ps in comparison to hyperplastic polyps (HPs).
Methods: A total of 64 cases of serrated polyps (≥10 mm in size), including 53 SSA/Ps and 11 HPs, were included in
the present study. Immunostaining was performed using a labeled streptavidin-biotin method. REG Iα expression was
classified as follows: (i) expression of endocrine cells: grade 0 (a few positive cells) to 3 (marked increase in positive cells);
(ii) expression of goblet cells: grade 0 (negative) to 2 (positive for crypts and surface epithelial cells); (iii) staining
intensity of goblet cells: grade 0 (negative) to 2 (strong); (iv) staining intensity of crypt (absorptive) cell membranes:
grade 0 (negative) to 2 (strong). The presence of aberration of crypt cell compartmentalization was assessed using
Ki67 immunostaining.
Results: With regard to the REG Iα expression of endocrine cells, 8 out of 11 HPs (73%) were grade 0, whereas 51
of 53 SSA/Ps (96%) were grade 1 or higher (p < 0.001). With regard to the distribution of REG Iα-immunoreactive
goblet cells, 10 of 11 HPs (91%) were grade 1, whereas 50 of 53 SSA/Ps (94%) were grade 2 (p < 0.001). A similar
trend was found in the staining intensity of goblet cells or crypt cell membranes (p = 0.011). Aberration of crypt
cell compartmentalization was more frequently identified in SSA/Ps (72%) than in HPs (18%; p = 0.002). A
significant association was observed between REG Iα overexpression and the aberration of crypt cell
compartmentalization in serrated polyps (p = 0.037).
Conclusions: REG Iα overexpression is a characteristic of SSA/Ps, which appears to reflect aberration of crypt cell
compartmentalization.
Virtual slides: The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/
vs/7240956081100040
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Table 1 Clinicopathological characteristics of colorectal
serrated polyps studied
SSA/P
(n = 53)
HP
(n = 11)
Gender
Male 28 6
Female 25 5
Age (yrs)* 55.4 (35–77) 59.3 (38–69)
Location
Cecum 13 1
Ascending colon 16 3
Transverse colon 17 3
Descending colon 3 0
Sigmoid colon 4 3
Rectum 0 1
Tumor size (mm)* 13.2 (10–30) 10.6 (10–15)
*Age and tumor size are represented as mean (range).
SSA/P: sessile serrated adenoma/polyp; HP: hyperplastic polyp.
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In 1996, Torlakovic and Snover were the first to describe
sessile-type serrated adenoma of the colon in an analysis
of serrated adenomatous polyposis with the development
of adenocarcinoma [1]. In 2003, Torlakovic et al. [2] re-
fined the criteria and proposed a subclassification of
colorectal serrated polyps into hyperplastic polyps (HPs),
traditional serrated adenomas, and sessile serrated aden-
omas. The last category of serrated polyps is now desig-
nated as sessile serrated adenomas/polyps (SSA/Ps) in
the fourth edition of the WHO Classification of Tumors
of the Digestive System [3]. Although SSA/Ps and large
HPs (≥10 mm in diameter), the latter was introduced by
Warner et al. in 1994 [4], were synonymously used at
times [5], SSA/Ps were histologically separated from
large HPs [6,7]. SSA/Ps were characterized by irregular
and asymmetrical distribution of Ki67-positive cells, which
frequently varied among crypts and involved the crypt
length to a variable extent; the pattern was designated as
“aberration of crypt cell compartmentalization” [8]. This is
consistent with the results of computer-assisted cyto-
metric analysis of Ki67 immunoreactivity in SSA/Ps [6].
However, aberration of crypt cell compartmentalization
was not a characteristic of large HPs as well as conven-
tional (small) HPs [6,7].
The regenerating gene (REG) Iα protein, the human
homologue of the rat REG protein, was originally iso-
lated from regenerating pancreatic islets [9], which
were immunohistochemically positive for acinar, but
not from islet cells of the pancreas [10]. REG Iα pro-
tein has been found to be expressed in normal colorec-
tal mucosa and colorectal tumors [11]. REG Iα is also
involved in the ulcerative colitis-neoplasia sequence
[12,13]. Previous experimental studies have shown that
REG Iα promotes cell growth and/or anti-apoptosis of
cancer cells [12,14].
A link between REG Iα and β-catenin has been demon-
strated in a study of liver cancer, in which β-catenin muta-
tions induced REG Iα expression in liver cancer cells [15].
In this context, REG Iα expression together with aberrant
β-catenin expression was associated with high Ki67 immu-
noreactivity in salivary gland tumors [16]. Recent studies
have detected aberrant nuclear accumulation of β-catenin
in SSA/Ps [17,18]. Wnt stimulation has been shown to
lead to the inactivation of APC and the activation of β-
catenin, resulting in nuclear accumulation of β-catenin,
which subsequently complexes with the T-cell factor/
lymphoid enhancer factor to activate target gene tran-
scription resulting in cell proliferation [19]. These findings
suggest that activation of Wnt/β-catenin signaling is asso-
ciated with aberration of crypt cell compartmentalization
in SSA/Ps.
The aim of this study was to investigate the expression
of REG Iα in a subset of SSA/Ps and HPs and to discussits expression in relation to nuclear β-catenin expression
and aberration of crypt cell compartmentalization.
Methods
Tissue samples and histological examination
Samples of 154 cases of serrated polyps (≥10 mm in size)
were obtained from the Dokkyo Medical University
Hospital and its affiliated institutions between 2003 and
2010. The diagnosis of SSA/P was made when a serrated
lesion had two or more of the following three findings:
irregularly branching crypts (>10% of the lesion), hori-
zontally arranged basal crypts (inverted T- and/or L-
shaped crypts) (>10% of the lesion), and crypt dilatation
(>10% of the lesion), according to a previous report [6].
Serrated polyps with only one of the three findings were
designated as intermediate type, and this type was in-
cluded in HPs. Criteria for HP included narrow straight
crypts with a normal distribution of the proliferative
zone at the base of the crypts with uniform maturation
and serration toward the surface [3]. Cases of mixed
serrated polyps and conventional adenoma or traditional
serrated adenoma were excluded. Some of the serrated
polyps were excluded because of poor orientation of the
specimens. Finally, a total of 64 cases of serrated polyps,
including 53 SSA/Ps and 11 HPs (histologically renamed
large HPs), were included in the present study. Clinico-
pathological characteristics of the serrated polyps studied
are summarized in Table 1.
The ethics committee of the Dokkyo Medical University
School of Medicine approved all protocols, and informed
consent for tissue procurement was obtained from all
patients. This work was conducted in a blinded manner
using a linkable anonymizing method. Samples used in
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ment, but not for research purposes. Participation in the
present study did not increase the medical disadvantage or
risk for patients.
Immunohistochemistry
Immunohistochemical staining for REG Iα and Ki67 was
performed with an LSAB-2 kit (Dako, Glostrub, Denmark)
as described previously [13,20]. In brief, 4-μm sections
were placed on slides, deparaffinized, rehydrated, and then
pretreated with 0.3% H2O2 in methanol for 20 min at
room temperature to quench endogenous peroxidase
activity. The slides were then placed in 0.01 ml/L citrate
buffer (pH 6.0) and treated by microwave heating
(400 W, 95°C; MI-77; Azumaya, Tokyo, Japan) to facilitate
antigen retrieval.
The sections were first incubated with 1% bovine serum
albumin in phosphate-buffered saline (PBS; pH 7.2) for
30 min and then with an anti-REG Iα antibody (the source
of the antibody is described in reference [10]; dilution
1:2,000) and anti-Ki67 antibody (DAKO; dilution 1:50)
for 1 h. Thereafter, the sections were incubated with a
biotinylated secondary antibody for 15 min, washed
with PBS, and treated with peroxidase-conjugated strep-
tavidin for 20 min. Finally, the sections were incubated
in 3, 3′-diaminobenzidine tetrahydrochloride (Liquid
DAB + Substrate Chromogen System; Dako, USA) with
0.05% H2O2 for 3 min and then counterstained with
Mayer’s hematoxylin.
Evaluation of immunohistochemical staining
In normal colon, REG Iα expression is found in goblet
cells and endocrine cells [13]. Furthermore, by using
immunohistochemistry for chromogranin A, REG Iα
has been confirmed to be present exclusively in endocrine
cells [21]. REG Iα positive endocrine cells are pyramidally
shaped and closed with a broad base that directly abuts
the basement membrane. We therefore classified the ex-
pression of REG Iα in a semiquantitative method accord-
ing to the following scheme: (i) expression of endocrine
cells: grade 0, a few (<1% of crypt cells) positive cells at
the bottom of the crypt; grade 1, mild increase (1-5% of
crypt cells) in the expression at the bottom of the crypt;
grade 2, moderate increase (6-10% of crypt cells) in the ex-
pression at the bottom of the crypt and/or slight increase
in the expression extending upward to surface epithelial
cells; grade 3, marked increase (>10% of crypt cells) in the
expression in crypt and surface epithelial cells; (ii) expres-
sion of goblet cells: grade 0, negative; grade 1, expression
in crypt cells, but not in surface epithelial cells (≤50% of
crypt cells); grade 2, expression in crypt and surface epi-
thelial cells (>50% of crypt cells); (iii) staining intensity
of goblet cells: grade 0, negative staining in goblet cells;
grade 1, weak expression; grade 2, strong expression;(iv) staining intensity of crypt (absorptive) cell mem-
branes: grade 0, negative expression in any epithelial
cell membrane; grade 1, weak membranous expression;
grade 2, strong membranous expression. Immunostaining
was evaluated in most representative areas showing high-
est intensity. Representative microphotographs of REG Iα
expression are illustrated in Figure 1.
We assessed the presence of aberration of crypt cell
compartmentalization using Ki67 immunostaining and ap-
plied the criteria for aberration of crypt cell compartmen-
talization as described by Torlakovic et al. [8] as follows:
an irregular distribution of Ki67-immunoreactive cells,
which frequently varied among crypts, involved the crypt
length to a variable extent, and was asymmetric in each in-
dividual crypt. Aberration of crypt cell compartmen-
talization was considered to be present when this feature
existed in more than 10% of the crypt.
Every slide was examined simultaneously by four au-
thors (KO, TY, HM, and TF) using a multi-head micro-
scope, without prior knowledge of the clinicopathological
data. In case of disagreement in the assessment of REG Iα
expression and the presence of aberration of crypt cell
compartmentalization, the slide was re-examined and
consensus was reached on further review.
Statistical analysis
Categorical analysis of variables was performed using ei-
ther the chi-squared test (with Yates’ correction) or Fisher’s
exact test, as appropriate. Continuous data were compared
with the Mann-Whitney U-test. A p value of <0.05 was
considered statistically significant. All statistical analyses
were carried out using the R software (version 2.15.0).
Results
With regard to the REG Iα expression of endocrine cells,
8 out of 11 HPs (73%) were grade 0 and 51 of 53 SSA/Ps
(96%) were grades 1 to 3 (p <0.001). With regard to REG
Iα expression of goblet cells, 10 of 11 HPs (91%)
were grade 1 and 50 of 53 SSA/Ps (94%) were grade
2 (p <0.001); a similar trend was found in the REG Iα
staining intensity of goblet cells (p <0.001). None of the
HP cases showed crypt cell membrane expression of
REG Iα, but 26 of 53 SSA/Ps (49%) were positive for
membranous expression (p =0.011; Table 2). The sum
of the grading scores for the four items described
above ranged from 2 - 9 (median, 6) in SSA/Ps and 2 - 4
(median, 3) in HPs; the values were significantly higher in
SSA/Ps than in HPs (p <0.001). The expression patterns
of REG Iα in representative cases of SSA/Ps and HPs
are illustrated in Figure 2. In a case of HP, diagnosed as
inverted HP by serial sections, REG Iα expression of
goblet cells was grade 2 (Figure 3).
Aberration of crypt cell compartmentalization was more
frequently identified in SSA/Ps (38 of 53 [72%]) than in
Table 2 Immunoreactivity of REG Iα in SSA/Ps and HPs
REG Iα expression SSA/P
(n = 53)
HP
(n = 11)
p value
Distribution of endocrine cells <0.001
Grade 0 2 8
Grade 1 30 1
Grade 2 17 2
Grade 3 4 0
Distribution of goblet cells <0.001
Grade 0 0 0
Grade 1 3 10
Grade 2 50 1
Staining intensity of goblet cells <0.001
Grade 0 0 0
Grade 1 5 7
Grade 2 48 4
Staining intensity of crypt cell membrane 0.011
Grade 0 27 11
Grade 1 19 0
Grade 2 7 0
SSA/P: sessile serrated adenoma/polyp; HP: hyperplastic polyp.
Figure 1 Immunohistochemical assessment (grading) of REG Iα expression.
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onstrated aberration of crypt cell compartmentalization.
In addition, we examined the association of REG Iα
expression with aberration of crypt cell compartmen-
talization. In a combined analysis of SSA/Ps and HPs,
high REG Iα expressors (sum of the grading score ≥5)
were more frequent in serrated polyps with aberration
of crypt cell compartmentalization (37 out of 40 [93%])
than in those without (14 out of 24 [58%]; p =0.037).
We performed an ancillary immunohistochemical study
of β-catenin (monoclonal antibody, Transduction Labora-
tories, Lexington, KY; dilution 1:2,000) in a case of SSA/P
(Figure 4). In this case, nuclear and cytoplasmic expression
of β-catenin was evident at the bottom of the crypt, simi-
lar to REG Iα.
Discussion
This is the first report to analyze REG Iα expression and
crypt cell compartmentalization in serrated polyps. We
show that REG Iα overexpression is a characteristic of
SSA/Ps, as compared to (large) HPs. In analyses of
ulcerative colitis-associated neoplasia, the expression of
REG Iα gradually increased from regenerative mucosa
through low-grade dysplasia to high-grade dysplasia; in
this sequence, the distribution of proliferative cells
increased similar to the REG Iα-positive region [12,13].
In addition, REG Iα-positive pleomorphic adenoma of
the salivary gland demonstrated a significantly higher
Figure 2 Histology and immunohistochemistry for REG Iα and Ki67 of SSA/P and HP. (A) SSA/P showing irregularly branching crypts,
horizontally arranged basal crypts, and crypt dilatation (hematoxylin & eosin); (B) REG Iα is mainly expressed in goblet cells in the entire crypt and
surface epithelium in SSA/P (immunoperoxidase); (C) Ki67-immunoreactive cells in SSA/P are either increased or decreased or both, with irregular
distribution; (D) HP represents narrow-shaped crypts without luminal serration in the basal part (hematoxylin & eosin); (E) REG Iα is weakly and sparsely
expressed in goblet cells in HP (immunoperoxidase); (F) Ki67-immunoreactive cells are distributed regularly in the basal part of crypts in HP.
Figure 3 A case of inverted HP in the ascending colon. (A) Epithelial misplacement into the submucosa (arrows); (B) micropapillary projection
at the surface area; (C) diffuse positivity for REG Iα in misplaced glands of the submucosa as well as in all glands of the mucosa; (D) REG Iα
positivity representing goblet cells in the surface epithelium.
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Figure 4 Expressions of REG Iα and β-catenin in serial sections of a case of SSA/P. (A) Diffuse REG Iα expression observed in the whole
crypt cell population and surface epithelial cells; (B) strong cytoplasmic REG Iα staining mainly in cells at the bottom of the crypt (magnifying
view of ‘box’ in figure A); (C) β-catenin is expressed mainly in the cell membrane, except at the bottom of the crypt; (D) note expression of
nuclear and cytoplasmic β-catenin at the bottom of the crypt, similar to REG Iα (magnifying view of ‘box’ in figure C).
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In previous reports, SSA/Ps demonstrated high prolifera-
tive activity with asymmetric localization of proliferative
cells [6-8]. This observation is in line with our results that
aberration of crypt cell compartmentalization was more
frequently identified in SSA/Ps (72%) than in HPs (18%).
We also found a significant association between REG Iα
overexpression and aberration of crypt cell compartmen-
talization in serrated polyps. In normal colonic crypts,
endocrine cells and Paneth cells exist, in general, in prolif-
erative and intermediate regions, and goblet cells are
present only in the intermediate region [19]; however, in
SSA/Ps, numerous goblet cells are identified at the base of
the crypts (proliferative region) as well as in the intermedi-
ate region [2]. In SSA/Ps, there are abnormalities in the lo-
cation of the various compartments (previously referred to
as abnormal proliferation or dysmaturation [2]), a feature
that Torlakovic et al. designated as the aberration of crypt
compartmentalization [8].
Interestingly, we found that REG Iα-expressing endo-
crine cells are increased in SSA/Ps. To our knowledge,
endocrine cell hyperplasia has not been previously de-
scribed in the context of SSA/Ps. In microvesicular-type
HP, the number and/or size of endocrine cells are in-
creased and they are mainly found in the intermediate
region of the crypts [2]. Recently, Naert et al. reported a
case of large cell neuroendocrine carcinoma arising in
an SSA [22]. Corresponding to this case and our find-
ings, REG Iα is thought to be associated with endocrine
cell hyperplasia and the development of neuroendocrinetumors in SSA/Ps. Mutations in REG Iα were identified
in patients with carcinoid tumors [23], suggesting a link
between its gain-of-function mutation and endocrine
cell hyperplasia.
In our ancillary study, REG Iα positivity was related to
aberrant (non-membranous type) β-catenin expression
in SSA/Ps. In conjunction with this finding, aberrant β-
catenin expression was related to REG Iα positivity in
pleomorphic adenoma [16]. A link between REG Iα and
β-catenin has been demonstrated in a study of liver cancer,
in which β-catenin mutations induced REG Iα expression
in liver cancer cells [15,16]. Therefore, REG Iα may be a
possible downstream target of the Wnt/β-catenin signal-
ing pathway. Wu et al. found aberrant nuclear labeling for
β-catenin in 9 of 22 cases of SSA/Ps (41%). In a recent
study, widespread or focal nuclear accumulation of β-
catenin (using an N-terminus antibody) was also identified
in 14 of 35 right-sided SSA/Ps (40%). Consequently, REG
Iα overexpression may contribute to the early activation of
the Wnt/β-catenin signaling pathway in SSA/Ps.
In the present study, we found one case of inverted HP
displaying REG Iα overexpression in the ascending colon
with a maximum diameter of 15 mm. This is the only case
of HP with REG Iα overexpression similar to SSA/Ps.
Inverted HPs as first described by Sobin et al. are an un-
usual morphological variant of HPs that show epithelial
misplacement into the submucosa [24]. Inverted HPs are
located in the rectum or sigmoid colon; their mean size is
5 mm [25]. To date, a small number of cases of inverted
HP associated with adenoma and adenocarcinoma have
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inverted HPs in addition to their ability of malignant
progression remains unknown and an area of research
and controversy.Conclusions
This is the first report to demonstrate a correlation between
SSA/P and REG Iα expression. REG Iα overexpression is a
characteristic of SSA/Ps, which might be associated with
aberration of crypt cell compartmentalization.
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